MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 81 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $141,000 | -25.4% | 15,039 | -5.6% | 0.06% | -11.3% |
| Q4 2021 | $189,000 | +46.5% | 15,932 | +40.6% | 0.07% | +24.6% |
| Q3 2021 | $129,000 | -39.7% | 11,335 | -5.0% | 0.06% | -35.2% |
| Q2 2021 | $214,000 | -39.7% | 11,930 | -47.9% | 0.09% | -41.3% |
| Q1 2021 | $355,000 | +29.1% | 22,912 | +1.8% | 0.15% | +31.6% |
| Q4 2020 | $275,000 | -33.6% | 22,503 | -30.2% | 0.11% | -47.5% |
| Q3 2020 | $414,000 | – | 32,237 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
| VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
| Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
| 683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
| Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
| Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
| Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
| Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |